GVR Report cover qPCR Instruments Market Size, Share & Trends Report

qPCR Instruments Market Size, Share & Trends Analysis Report By Instrument (GeneXpert, BioFireFilmArray Systems, BMS Mic System), By Region (North America, Europe, APAC, LATAM, MEA), And Segment Forecasts, 2021 - 2028

  • Published Date: Sep 2021
  • Report ID: GVR-4-68038-339-3
  • Number of Pages: 109
  • Format: Electronic (PDF)
  • Historical Data: 2017 - 2019

Report Overview

The global qPCR instruments market size was valued at USD 1.07 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 3.4% from 2021 to 2028. The growing prevalence of diseases, technological advancements, and increasing demand for qPCR instruments are anticipated to drive the market over the forecast period. Increased focus on diagnostics attributed to the spread of COVID-19 is projected to propel the demand for qPCR instruments in the upcoming years. The demand for qPCR equipment and consumables is being driven by the SARS-CoV-2 pandemic. The spike in the incidence of COVID-19 is expected to add significantly to the number of preventive screenings. This can be attributed to the fact that the number of COVID-19 patients cannot be ascertained without proper screening owing to a large number of asymptomatic cases.

North America qPCR instruments market size, by instrument, 7500, 2018 - 2028 (USD Million)

The launch of new products is expected to change certain market dynamics as it can increase the threat of internal substitution. Furthermore, increasing consumers’ preference for updated and advanced products is creating a demand for technologically advanced products, such as the Mic qPCR system with Bluetooth connectivity and multiple devices that can be connected to the computer simultaneously to run multiple sample sets.

The prevalence of chronic diseases, infectious diseases, and genetic disorders, such as Alzheimer’s, Turner syndrome, and Parkinson’s, has increased rapidly, which is expected to fuel the market growth. According to the CDC, chronic diseases such as cancer, diabetes, kidney diseases, and respiratory diseases, including asthma, are accountable for 7 in 10 deaths in the U.S. each year. Faster detection of diseases with PCR can allow for timely and appropriate treatment.

Increasing adoption of qPCR technologies is expected to propel this market growth. The adoption of qPCR techniques is increasing owing to their accuracy, automation, precise results, real-time quantification, and sensitivity. qPCR offers a wide range of input nucleic acids, making it an effective and useful technology in research applications.

Instrument Insights

The GeneXpert segment accounted for the largest revenue share of over 20.0% in 2020 and is expected to witness the fastest growth over the forecast period. This is attributed to its increased adoption rate during the SARS-CoV-2 pandemic for the detection of infections. This system provides 24/7 testing accuracy, workflow flexibility, and user-friendly designs. They offer multiple tests on a single, scalable, and consolidated workstation. Key features of this system include high adjustability, touchscreen, increased accumulator capacity, expanded conveyor and loading zone, expanded test shuttle, and self-containment. It also has a faster, quieter, and more robust robotic gantry.

Global Qpcr instruments market share, by instrument, 2020 (%)

The BioFire FilmArray systems segment held the second-largest revenue share in 2020 owing to rapid and accurate automated detection of infections and pathogens in blood, gastrointestinal, meninges, and respiratory tract with the instrument. The instrument is available in BioFire Torch System and BioFire FilmArray 2.0 versions.

The BMS Mic system segment is anticipated to grow owing to its low weight, making it portable and easy to handle. Fast PCR results are provided by the equipment by completion of 32 PCR cycles in 25 minutes. In addition, features such as Bluetooth can enhance its connectivity to a PC or laptop. Furthermore, multiple Mic qPCR systems can be connected to one operating computer, thereby enhancing the number of samples that can be tested to get results.

Regional Insights

North America accounted for the largest revenue share of 40.82% in 2020 and is expected to maintain its lead over the forecast period. The growth of this regional market is attributed to the growing regulatory support and increasing launches of novel products. The large number of instruments installed in North America, as compared to other regions, demonstrates its high diagnostic capacity. However, it reduces the opportunity for the installation of new instruments.

Asia Pacific is expected to be the fastest-growing regional market over the forecast period. The major untapped opportunities in the form of unmet medical needs, increasing initiatives for scientific research, and positive economic growth are primary growth drivers of this market.

Furthermore, the growing number of investments and strategic initiatives by new players are accelerating the market growth in the European region. For instance, in January 2020, The Discovery Labs collaborated with Deerfield Management Company to find a gene therapy CDMO with USD 1.1. billion investments.

Key Companies & Market Share Insights

The market for qPCR instruments is competitive and the key players are constantly adopting new strategies to gain dominance in the market. Companies are developing novel instruments to capture a share of this lucrative market. For instance, in November 2020, Streck announced the launch of its novel qPCR instrument Zulu RT that can be used to perform four experiments simultaneously and independently. The greater flexibility of this instrument was expected to help capture a share in the market.

Real-time PCR has various significant external substitutes, including advanced instruments like dPCR and newly developed nanoplasmonic PCR. Key players are making use of their existing consumer pool in the region to provide additional products and generate more business. This strategy is useful for brands that have already built trust in the market. Some prominent players in the global qPCR instruments market include:

  • Thermo Fisher Scientific, Inc.

  • F. Hoffmann-La Roche Ltd.

  • Bio-Rad Laboratories, Inc.

  • Danaher Corporation

  • Qiagen

  • Agilent Technologies, Inc.

  • Abbott

  • bioMérieux SA

  • Quantabio

  • Azure Biosystems, Inc.

  • Bio Molecular Systems

qPCR Instruments Market Report Scope

Report Attribute


Market size value in 2021

USD 898.98 million

Revenue forecast in 2028

USD 1,394.75 million

Growth Rate

CAGR of 3.4% from 2021 to 2028

Base year for estimation


Historical data

2017 - 2019

Forecast period

2021 - 2028

Quantitative units

Revenue in USD million/billion and CAGR from 2021to 2028

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Instrument, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; China; India; Japan; Brazil; Mexico; South Africa; UAE

Key companies profiled

Thermo Fisher Scientific, Inc.; F. Hoffmann-La Roche Ltd.; Bio-Rad Laboratories, Inc.; Danaher Corporation; Qiagen; Agilent Technologies, Inc.; Abbott; bioMérieux SA; Quantabio; Azure Biosystems, Inc.; Bio Molecular Systems

Customization scope

Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail of customized purchase options to meet your exact research needs. Explore purchase options

Segments Covered in the Report

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2017 to 2028. For the purpose of this study, Grand View Research has segmented the global qPCR instruments market report on the basis of instrument and region:

  • Instrument Outlook (Revenue, USD Million, 2017 - 2028)

    • 7500

    • QuantStudioDx Real-Time PCR System

    • QuantStudio 5 Real-Time PCR System

    • ViiA 7 Dx

    • StepOne/ StepOne Plus

    • LightCycler 2.0/ 96/ 480/ 1536

    • Cobas 4800

    • CFX96

    • SmartCycler

    • GeneXpert

    • Rotor-Gene Q 5Plex HRM System

    • Rotor-Gene Q

    • BioFireFilmArray Systems

    • BMS Mic System

  • Regional Outlook (Revenue, USD Million, 2017 - 2028)

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

      • France

      • Italy

      • Spain

    • Asia Pacific

      • Japan

      • China

      • India

    • Latin America

      • Brazil

      • Mexico

    • Middle East & Africa

      • South Africa

      • UAE

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.